))
S2 E1 - Arvind Dasari, MD MS – Emerging Treatments in Colorectal Cancer
Manage episode 407348225 series 3559566
Innehåll tillhandahållet av Karger Publishers. Allt poddinnehåll inklusive avsnitt, grafik och podcastbeskrivningar laddas upp och tillhandahålls direkt av Karger Publishers eller deras podcastplattformspartner. Om du tror att någon använder ditt upphovsrättsskyddade verk utan din tillåtelse kan du följa processen som beskrivs här https://sv.player.fm/legal.
This is the first episode in our series on colorectal cancer which aims to update clinicians on the latest developments in treatment.
In this episode, Dr. Arvind Dasari starts by explaining the current management of colorectal cancer, and then outlines the latest developments in immunotherapy and targeted therapies, touching on specific trials presented at ASCO GI 2023. Trials discussed include Phase III SUNLIGHT, Phase III Fresco-2 and PARADIGM.
For more podcast episodes from Karger please visit karger.com/pages/podcasts.
This podcast was funded by Taiho Oncology, Inc. The faculty and publisher are solely responsible for this content. Taiho does not recommend or endorse the use of its products other than as described in the approved labeling. The content of this site is not medical advice and does not replace independent medical judgment.
17 episoder
Dela
